Streetbeat News

Price Targets

HTLF

Stephens & Co. analyst Terry McEvoy maintains an Overweight rating on Heartland Financial USA (NASDAQ:HTLF) but lowers the price target from $38 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:08 pm

BCS

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on TMX Group (TSX:X) and lowers the price target from C$32 to C$31.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:06 pm

ADUS

Stephens & Co. analyst Scott Fidel maintains an Overweight rating on Addus HomeCare (NASDAQ:ADUS) but lowers the price target from $110 to $105.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:05 pm

ZBRA

Stephens & Co. analyst Tommy Moll maintains an Overweight rating on Zebra Technologies (NASDAQ:ZBRA) but lowers the price target from $350 to $300.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:03 pm

PFE

Barclays analyst Carter Gould has maintained an Equal-Weight rating on Pfizer (NYSE:PFE) but lowered the price target from $35 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:03 pm

PAYC

Barclays analyst Raimo Lenschow has maintained an Equal-Weight rating on Paycom Software (NYSE:PAYC) but lowered the price target from $294 to $200.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:01 pm

MSCI

Barclays analyst Manav Patnaik has maintained an Overweight rating on MSCI (NYSE:MSCI) but lowered the price target from $650 to $600.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 2:00 pm

FSBC

Stephens & Co. analyst Andrew Terrell maintains an Overweight rating on Five Star (NASDAQ:FSBC) but lowers the price target from $27 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:59 pm

JD

Barclays analyst Jiong Shao has maintained an Overweight rating on JD.com, but has lowered the price target from $52 to $45.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:59 pm

INGR

Barclays analyst Benjamin Theurer has maintained an Equal-Weight rating on Ingredion (NYSE:INGR) and lowered the price target from $118 to $110.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:58 pm